1F1

0.0050.00%
CP

Chade Phang Tan

Lead Independent Director

Mr. Chade Phang Tan, also known as Roger, is Lead Independent Director of Aoxin Q & M Dental Group Limited from April 28, 2026. Mr. Tan serves as Non-Executive Independent Director of Tritech Group Limited since January 01, 2024. He was Independent and Non-Executive Director of SMI Vantage Limited (formerly known as Singapore Myanmar Investco Limited) (formerly known as Singapore Windsor Holdings Limited) since September 1, 2023 until January 2025. He serves as an Independent Director at Y Ventures Group Ltd. since August 1, 2021 and serves as its Lead Independent Director since April 29, 2026. He served as Lead Independent Non-Executive Director of Camsing Healthcare Limited since March 22, 2021. He was an Independent Director at Revez Corporation Ltd. since February 28, 2021 until March 2023. He has been the Chief Executive Officer and founder of Voyage Research Pte Ltd (previously known as SIAS Research) since January 2009, which he founded in 2009. He was an Independent Non-Executive Director at TBK & Sons Holdings Limited since September 5, 2019, until October 28, 2020. He was Independent Director of TIH Limited from June 1, 2018, to April 22, 2021. Mr. Tan serves as Director of Small and Middle Capitalization Companies Association since November 2015 and served as the President since November 2015 to 2017, where he actively tries to gather small and middle capitalization companies within a single entity to work closely with the authorities and professionals to improve the visibility and governance standards of its members. He was an Investment Analyst in Standard Chartered Bank Singapore from January 2007 to December 2008. He has professional experience in finance and business analysis. He served as the Lead Investment Analyst SIAS Research from August 2005 to December 2006. He has work experience and occupation(s) during the past many years. He served as an Independent Director of Dapai International Holdings Co. Ltd. since March 1, 2016, until July 2018. He served as Independent Non-Executive Director of Luminor Financial Holdings Limited since February 18, 2016 until April 28, 2025 and served as Independent Director of International Healthway Corporation Limited (now OUE Healthcare Limited (formerly known as OUE Lippo Healthcare Limited since January 23, 2017 until April 24, 2026. He served as Lead Independent and Non-Executive Director at OUE Healthcare Limited (formerly known as OUE Lippo Healthcare Limited) since July 17, 2017 until April 24, 2026. He serves as an Independent Director of International Healthcare Corporation Limited since January 23, 2017. He served as Director and Partner at An Le Management Pte. Ltd. Until April 29, 2008, Bodhi Tree Network Pte. Ltd since August 21, 2017, until September 4, 2018, JX Domu Pte. Ltd until September 5, 2018, Oaktree Associates Pte. Ltd until October 27, 2006 and Palace Management Pte. Ltd until August 4, 2007. He served as a Non-Executive Independent Director of Transcorp Holdings Limited from May 23, 2017, to February 27, 2018. He serves as a Director of Voyage Research Pte Ltd. since January 2009. Mr. Tan holds a Bachelor of Business in Accountancy Degree from RMIT University in 2000 and Master of Finance from the same university in 2002 and earned his Diploma in Risk and Insurance Management from Nanyang Polytechnic in1997.

Positions